Cabergolinum review

Cabergolinum is a combination of derived ergot fungi alkaloids used to treat Parkinsons disease, and some hormone problems such as excessive prolactin production. This medication is used to prevent and inhibit progressive breast milk production in lactating mothers, but is not as effective when the patient has recently given birth. Additionally, this medication can be used to impede functional output of prolactin producing or causing tumors and as a hormone regulator for certain types of ovarian diseasees.

In a cellular level, this medication inhibits dopamine receptors in the hypothalamus, more specifically in the lactophilic cells, which in turn inhibits the reception of signals in the pituitary gland to release prolactin. Cabergolinum is considered an effective alternative to Bromocriptine if the latter is ineffective in treating prolactin production disorders.

Patients with early onset symptoms of Parkinson's disease may benefit from single medication type therapy with Cabergolinum. It may also be used in conjunction with certain medicaments such as levodopa or carbidopa to treat much later stages of Parkinson's.

This medication is also prescribed by physicians to treat microprolactinomas (a malfunction of the prolactin producing tumors in the pituitary gland). This is highly effective for patients having hyperactive pituitary glands.

As an alternative for Bromocriptine, Cabergolinum may also be used to treat amenorrhea, anovulation, and galactorrhea. In some cases, Cabergolinum has been used to heighten and correct issues pertaining to libido dysfunction and anorgasmia. Bodybuilders have taken advantage of the medication's effects as a means to combat the occurrence of gynecomastia, which is a common side effect of anabolic steroid medicaments.

As a monotherapeutic medication for Parkinson's disease, the recommended dose is an initial dose of .5 milligram daily and is increased to a dose of 2 to 4 milligram per day. As a combinant medication to levodopa or carbidopa, it may be adjusted to a maximum of 2 to 6 milligram dose daily.

For cancerous cells, tumors, and some hyperprolactinemic disorders, an initial 0.5 milligram dose per week may be prescribed, with a gradual increase to 4.5 milligram per week. Doctors may modify the recommended dose based on the patient's condition and their response to the treatment.

The most common side effect is weakness followed by exhaustion or body malaise. In more severe cases, vomiting is evident with combined headache and dizziness. You should immediately notify your doctor of any unusual symptoms after taking the medication. There have been cases where high blood pressure develops. Due to the effect of prolactin inhibition, pain in the breast area may be felt as an indirect effect to target tissue. Consult with your doctor is any of these symptoms arise.

Pregnant and lactating mothers should not take this medication unless absolutely necessary. Cabergolinum disrupts the normal development of the child with hormonal curbing. This medication is also known to pass through breast milk during breastfeeding and may pose a serious threat to the nursing baby.

Cabergolinum has the following structural formula:

Chemical structure of cabergolinum

• Molecular formula of cabergolinum is C26H37N5O2
Cabergolinum available : 0,5mg tablets

Generic name: Cabergoline

Brand name(s): Cabaser, Cabergolina, Dostinex

  Your Cabergolinum review